Other
Other accrued liabilities
Abbott Other accrued liabilities increased by 9.8% to $6.38B in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
A sudden increase may indicate rising operational overhead or pending settlements, while stability suggests predictable expense management.
Detailed definition
This captures miscellaneous short-term obligations that do not fall into specific categories like accounts payable or ac...
Peer comparison
Standard across all capital-intensive industries as a residual category for miscellaneous payables.
Metric ID:
other_other_accrued_liabilities_currentHistorical Data
2 periods
| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $5.81B | $6.38B |
| QoQ Change | — | +9.8% |
Range$5.81B – $6.38B
Other accrued liabilities at Other Companies
Frequently Asked Questions
- What is Abbott's other accrued liabilities?
- Abbott (ABT) reported other accrued liabilities of $6.38B in Q1 2026.
- What does other accrued liabilities mean?
- A catch-all category for various small, short-term debts owed to third parties.